Advertisement

Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer

  • Christina BluemelEmail author
  • Andreas Schnelzer
  • Asli Okur
  • Alexandra Ehlerding
  • Stefan Paepke
  • Klemens Scheidhauer
  • Marion Kiechle
Original Article

Abstract

Purpose

Sentinel lymph node biopsy (SLNB) is standard of care in early-stage breast cancer. Freehand SPECT (FhSPECT) is a system generating 3-D images for intraoperative visual detection of radioactivity in the body. The aim of our study was to evaluate the sensitivity of this technology for sentinel lymph node (SLN) detection and SLNB guidance.

Methods

In 40 patients, FhSPECT was additionally used after planar imaging and probe localization for SLNB. The number of SLNs detected was compared with the number detected by planar scintigraphy (reference method) and the conventional acoustic gamma probe (standard alternative). The sensitivity of FhSPECT was compared with that of the conventional gamma probe (McNemar’s test).

Results

FhSPECT mapped the SLNs in 92.3 % of the basins (36/39) intraoperatively in identical positions to those seen on planar scintigrams. The conventional gamma probe correctly detected the SLNs in 35 of 39 basins (89.7 %). After SLNB, remaining radioactivity was detected by FhSPECT in nine patients, resulting in additional resection of SLNs in four patients.

Conclusion

FhSPECT is a highly sensitive modality for intraoperative detection of SLNs, resulting in the identification of a higher number of SLNs than conventional gamma probe detection.

Keywords

Freehand SPECT FhSPECT Sentinel lymph node biopsy Image-guided surgery Breast cancer 

Notes

Conflicts of interest

None.

References

  1. 1.
    Buscombe J, Paganelli G, Burak ZE, Waddington W, Maublant J, Prats E, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging. 2007;34:2154–9. doi: 10.1007/s00259-007-0614-z.PubMedCrossRefGoogle Scholar
  2. 2.
    Lyman GH, Giuliano AE, Somerfield MR, Benson 3rd AB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20. doi: 10.1200/JCO.2005.08.001.PubMedCrossRefGoogle Scholar
  3. 3.
    Kuehn T, Bembenek A, Decker T, Munz DL, Sautter-Bihl ML, Untch M, et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer. 2005;103:451–61. doi: 10.1002/cncr.20786.PubMedCrossRefGoogle Scholar
  4. 4.
    Vogt H, Schmidt M, Bares R, Brenner W, Grunwald F, Kopp J, et al. Procedure guideline for sentinel lymph node diagnosis. Nuklearmedizin. 2010;49:167–72. doi: 10.3413/nukmed-321. quiz N19.PubMedCrossRefGoogle Scholar
  5. 5.
    Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16. doi: 10.1002/cncr.21568.PubMedCrossRefGoogle Scholar
  6. 6.
    Schirrmeister H, Kotzerke J, Vogl F, Buck A, Czech N, Koretz K, et al. Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. Cancer Biother Radiopharm. 2004;19:784–90. doi: 10.1089/cbr.2004.19.784.PubMedCrossRefGoogle Scholar
  7. 7.
    Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30:3726–33. doi: 10.1200/JCO.2012.41.8574.PubMedCrossRefGoogle Scholar
  8. 8.
    Ibusuki M, Yamamoto Y, Kawasoe T, Shiraishi S, Tomiguchi S, Yamashita Y, et al. Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system. Surg Oncol. 2010;19:88–94. doi: 10.1016/j.suronc.2009.04.001.PubMedCrossRefGoogle Scholar
  9. 9.
    Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 2009;16:2943–52. doi: 10.1245/s10434-009-0594-2.PubMedCrossRefGoogle Scholar
  10. 10.
    Scopinaro F, Tofani A, di Santo G, Di Pietro B, Lombardi A, Lo Russo M, et al. High-resolution, hand-held camera for sentinel-node detection. Cancer Biother Radiopharm. 2008;23:43–52. doi: 10.1089/cbr.2007.364.PubMedCrossRefGoogle Scholar
  11. 11.
    Kerrou K, Pitre S, Coutant C, Rouzier R, Ancel PY, Lebeaux C, et al. The usefulness of a preoperative compact imager, a hand-held gamma-camera for breast cancer sentinel node biopsy: final results of a prospective double-blind, clinical study. J Nucl Med. 2011;52:1346–53. doi: 10.2967/jnumed.111.090464.PubMedCrossRefGoogle Scholar
  12. 12.
    Wendler T, Hartl A, Lasser T, Traub J, Daghighian F, Ziegler SI, et al. Towards intra-operative 3D nuclear imaging: reconstruction of 3D radioactive distributions using tracked gamma probes. Med Image Comput Comput Assist Interv. 2007;10:909–17.PubMedGoogle Scholar
  13. 13.
    Wendler T, Herrmann K, Schnelzer A, Lasser T, Traub J, Kutter O, et al. First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT. Eur J Nucl Med Mol Imaging. 2010;37:1452–61. doi: 10.1007/s00259-010-1430-4.PubMedCrossRefGoogle Scholar
  14. 14.
    Paepke S, Schwarz-Boeger U, Kiechle M, Jacobs VR. Axillary Dissection with Access Minimized (ADAM): a new technique for lymph node dissection in conservative surgery for breast cancer. Int J Fertil Women’s Med. 2003;48:232–7.Google Scholar
  15. 15.
    Bezu C, Coutant C, Salengro A, Darai E, Rouzier R, Uzan S. Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol. 2011;20:e55–9. doi: 10.1016/j.suronc.2010.10.002.PubMedCrossRefGoogle Scholar
  16. 16.
    Johnson S, Arora S, Babu E. Injecting patent blue dye V for sentinel lymph node biopsy without skin staining. Ann R Coll Surg Engl. 2012;94:277–8. doi: 10.1308/003588412X13171221591259h.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Christina Bluemel
    • 1
    • 2
    Email author
  • Andreas Schnelzer
    • 3
  • Asli Okur
    • 1
    • 3
    • 4
  • Alexandra Ehlerding
    • 3
  • Stefan Paepke
    • 3
  • Klemens Scheidhauer
    • 1
  • Marion Kiechle
    • 3
  1. 1.Department of Nuclear Medicine, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  2. 2.Department of Nuclear MedicineUniversitätsklinikum WürzburgWürzburgGermany
  3. 3.Department of Obstetrics and Gynecology, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  4. 4.Computer Aided Medical Procedures (CAMP)Technische Universität MünchenMunichGermany

Personalised recommendations